Effective orally available drug combination of OR2100 and venetoclax in acute myeloid leukemia

被引：0
|
作者：
Ureshino, Hiroshi [1 ,2 ,3 ]
Watanabe, Tatsuro [2 ]
Kimura, Shinya [1 ,2 ]
机构：
[1] Saga Univ, Dept Hematol & Oncol, Saga, Japan
[2] Saga Univ, Dept Drug Discovery & Biomed Sci, Saga, Japan
[3] Hiroshima Univ, Res Inst Radiat Biol & Med, Higashihiroshima, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-1006
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [1] Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia
    Kamachi, Kazuharu
    Ureshino, Hiroshi
    Watanabe, Tatsuro
    Yoshida-Sakai, Nao
    Fukuda-Kurahashi, Yuki
    Kawasoe, Kazunori
    Hoshiko, Toshimi
    Yamamoto, Yuta
    Kurahashi, Yuki
    Kimura, Shinya
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (02): : 297 - 308
  • [2] Drug-drug interactions with venetoclax in acute myeloid leukemia
    Tubay, Saziye Esra
    Celik, Serhat
    Unal, Ali
    ISTANBUL JOURNAL OF PHARMACY, 2024, 54 (03): : 345 - 349
  • [3] Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia
    Guo, Xuejiao Shirley
    Atla, Sandeep
    Nyalata, Satyanarayana
    Alugubelli, Yugendar R.
    Chen, Peng-Hsun Chase
    Xu, Shiqing
    Liu, Wenshe Ray
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (22) : 20100 - 20117
  • [4] Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate
    Kawakatsu, Renshi
    Tadagaki, Kenjiro
    Yamasaki, Kenta
    Yoshida, Tatsushi
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [5] Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia
    Goulart, Hannah
    Kantarjian, Hagop
    Pemmaraju, Naveen
    Daver, Naval
    Dinardo, Courtney D.
    Rausch, Caitlin R.
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 23 - 37
  • [6] Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
    Brancati, Serena
    Gozzo, Lucia
    Romano, Giovanni Luca
    Vetro, Calogero
    Dulcamare, Ilaria
    Maugeri, Cinzia
    Parisi, Marina
    Longo, Laura
    Vitale, Daniela Cristina
    Di Raimondo, Francesco
    Drago, Filippo
    BLOOD, 2021, 138
  • [7] Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes
    Shimony, Shai
    Stone, Richard M.
    Stahl, Maximilian
    CURRENT OPINION IN HEMATOLOGY, 2022, 29 (02) : 63 - 73
  • [8] Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate
    Renshi Kawakatsu
    Kenjiro Tadagaki
    Kenta Yamasaki
    Tatsushi Yoshida
    Scientific Reports, 14
  • [9] Prioritization of Eleven-Nineteen-Leukemia (ENL) inhibitors as orally available drug candidates for acute myeloid leukemia
    Liu, Wenshe R.
    Guo, Xuejiao
    Alta, Sandeep
    Xu, Shiqing
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
  • [10] Venetoclax in acute myeloid leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 271 - 276
12345